Contour Health review

Take a quarter dose here and you pay about a quarter. That is rare enough to lead with. Contour prices the vial your weekly dose needs rather than a membership, and it publishes the vial size, what the vial costs and how many weeks it lasts, so you can check the arithmetic yourself. Nothing is gated behind a quiz, an account or a phone number. One quirk is worth knowing, and it works in your favor: the ladder is not a straight line, so stepping up one increment can move you onto a larger vial that lasts longer and drop your monthly cost rather than raise it. Read the ladder rather than assuming it. Two things could still catch you. Every figure is an estimate a clinician confirms at the consultation, not a locked price. And the pharmacy that fills it is never named.

Vs median

$69/mo below the $169 median across the 242 of 373 programs we track that publish a plain monthly rate

Market

$59–$1300/mo is the full published spread in our ranking

Structure

Charges less for less

Consult

Included in the price

Dietitian

Not included

Labs

Not required

Pricing

Varies by dose, plan or tier

Price last updated

August 2026

Contour Health does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.

Contour Health sells compounded semaglutide and tirzepatide as weekly self-injections, prescribed after a free consultation and filled by unnamed 503A compounding pharmacies. There is no subscription: you buy a vial, and its own cost calculator maps every weekly dose to a vial size, a vial price and the number of weeks that vial lasts. The calculator is open to anyone — no quiz, no account, no phone number — so a low-dose plan can be costed in full before you speak to anybody. Every figure is labeled an estimated cash price that a clinician confirms at the consultation before you pay.

Every figure is an estimate, not a quote — "Estimated cash price only. Your exact dose, vial size, and cost are confirmed by a licensed provider at your free consult — before you pay anything"

• The ladder does not rise steadily. Semaglutide at 1.25 mg/week is $200/month while 1.5 mg/week is $180/month, because the higher dose moves onto a 20 mg vial that lasts longer — so a step up in dose can be a step down in cost, and the ladder has to be read rather than assumed
• Buying by the vial means buying weeks ahead: a 2.5 mg semaglutide vial at 0.25 mg/week is stated to last about 10 weeks, so stopping early leaves you holding drug you have already paid for
• Its two listings of tirzepatide vials disagree — the calculator prices a 10 mg vial at $300, while its weight-loss pages start the tirzepatide range at 20 mg
• No compounding pharmacy is named, only "partnerships with leading 503A accredited compounding pharmacies" — and the FDA does not accredit or designate 503A pharmacies
• No list of states served is published anywhere
• Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven

Contour Health is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What the evidence actually shows
• What microdosing GLP-1 costs
• Low dose vs full dose
• What a flat price costs at a low dose
• The true annual cost of a plan